Literature DB >> 17313651

WD-repeat-propeller-FYVE protein, ProF, binds VAMP2 and protein kinase Czeta.

Thorsten Fritzius1, Alexander D Frey, Marc Schweneker, Daniel Mayer, Karin Moelling.   

Abstract

We have recently identified a protein, consisting of seven WD repeats, presumably forming a beta-propeller, and a domain identified in Fab1p, YOTB, VAC1p, and EEA1 (FYVE) domain, ProF. The FYVE domain targets the protein to vesicular membranes, while the WD repeats allow binding of the activated kinases Akt and protein kinase (PK)Czeta. Here, we describe the vesicle-associated membrane protein 2 (VAMP2) as interaction partner of ProF. The interaction is demonstrated with overexpressed and endogenous proteins in mammalian cells. ProF and VAMP2 partially colocalize on vesicular structures with PKCzeta and the proteins form a ternary complex. VAMP2 can be phosphorylated by activated PKCzeta in vitro and the presence of ProF increases the PKCzeta-dependent phosphorylation of VAMP2 in vitro. ProF is an adaptor protein that brings together a kinase with its substrate. VAMP2 is known to regulate docking and fusion of vesicles and to play a role in targeting vesicles to the plasma membrane. The complex may be involved in vesicle cycling in various secretory pathways.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17313651     DOI: 10.1111/j.1742-4658.2007.05702.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  8 in total

1.  Hepatic insulin resistance in ob/ob mice involves increases in ceramide, aPKC activity, and selective impairment of Akt-dependent FoxO1 phosphorylation.

Authors:  Mini P Sajan; Robert A Ivey; Mackenzie C Lee; Robert V Farese
Journal:  J Lipid Res       Date:  2014-11-13       Impact factor: 5.922

2.  BMI-related progression of atypical PKC-dependent aberrations in insulin signaling through IRS-1, Akt, FoxO1 and PGC-1α in livers of obese and type 2 diabetic humans.

Authors:  Mini P Sajan; Robert A Ivey; Robert V Farese
Journal:  Metabolism       Date:  2015-08-24       Impact factor: 8.694

3.  Isoform-specific regulation of Akt signaling by the endosomal protein WDFY2.

Authors:  Helena A Walz; Xiarong Shi; My Chouinard; Catherine A Bue; Deanna M Navaroli; Akira Hayakawa; Qiong L Zhou; Jonathan Nadler; Deborah M Leonard; Silvia Corvera
Journal:  J Biol Chem       Date:  2010-02-26       Impact factor: 5.157

4.  Akt- and Foxo1-interacting WD-repeat-FYVE protein promotes adipogenesis.

Authors:  Thorsten Fritzius; Karin Moelling
Journal:  EMBO J       Date:  2008-04-03       Impact factor: 11.598

5.  Peroxisome proliferator-activated receptor-gamma agonist improves skeletal muscle insulin signaling in the pregestational intrauterine growth-restricted rat offspring.

Authors:  Shilpa Oak; Cang Tran; Maria-Olivia Castillo; Shanthie Thamotharan; Manikkavasagar Thamotharan; Sherin U Devaskar
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-06-02       Impact factor: 4.310

6.  Substrate uptake and metabolism are preserved in hypertrophic caveolin-3 knockout hearts.

Authors:  Ayanna S Augustus; Jonathan Buchanan; Sankar Addya; Giuseppe Rengo; Richard G Pestell; Paolo Fortina; Walter J Koch; Andre Bensadoun; E Dale Abel; Michael P Lisanti
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-13       Impact factor: 4.733

7.  WDFY2 restrains matrix metalloproteinase secretion and cell invasion by controlling VAMP3-dependent recycling.

Authors:  Marte Sneeggen; Nina Marie Pedersen; Coen Campsteijn; Ellen Margrethe Haugsten; Harald Stenmark; Kay Oliver Schink
Journal:  Nat Commun       Date:  2019-06-28       Impact factor: 14.919

8.  Akt-dependent phosphorylation of hepatic FoxO1 is compartmentalized on a WD40/ProF scaffold and is selectively inhibited by aPKC in early phases of diet-induced obesity.

Authors:  Mini P Sajan; Mildred E Acevedo-Duncan; Mary L Standaert; Robert A Ivey; Mackenzie Lee; Robert V Farese
Journal:  Diabetes       Date:  2014-04-04       Impact factor: 9.461

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.